Drug Volatile Stocks: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Lannett Company (NYSE:LCI), MEI Pharma Inc (NASDAQ:MEIP), Teva Pharmaceutical Industries (NYSE:TEVA), Biogen Idec (NASDAQ:BIIB)

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced that it has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) on its lead drug plecanatide for the treatment of irritable bowel syndrome with constipation (IBS-C). Agreement was reached with the FDA for the plecanatide pivotal phase 3 IBS-C clinical development program that is scheduled to begin in the fourth quarter of this year. Synergy Pharmaceuticals Inc (NASDAQ:SGYP) weekly performance is -3.93%. On last trading day company shares ended up $3.91. Analysts mean target price for the company is $12.62. Synergy Pharmaceuticals Inc (NASDAQ:SGYP) distance from 50-day simple moving average is -4.99%.

Lannett Company (NYSE:LCI) major shareholder David Farber unloaded 7,500 shares of Lannett Company stock in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of $50.00, for a total value of $375,000.00. Following the transaction, the insider now directly owns 70,000 shares in the company, valued at approximately $3,500,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission. Lannett Company, Inc. (NYSE:LCI) shares fell -7.13% in last trading session and ended the day on $45.57. LCI Gross Margin is 48.70% and its return on assets is 13.50%. Lannett Company, Inc. (NYSE:LCI) quarterly performance is 44.48%.

On June 10,2014 MEI Pharma, Inc. (Nasdaq: MEIP) announced preliminary response data from the first stage of a two-stage, open-label Phase II clinical study of its investigational drug candidate Pracinostat in combination with Vidaza® (azacitidine) in elderly patients with newly diagnosed acute myeloid leukemia (AML) who are unsuitable for intensive chemotherapy.MEI Pharma Inc (NASDAQ:MEIP) shares moved down -2.88% in last trading session and was closed at $6.07, while trading in range of $5.91-$6.54. MEI Pharma Inc (NASDAQ:MEIP) year to date performance is -24.22%.

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) continued its efforts to ward off generic competition for its multiple sclerosis drug Copaxone by filing a citizen’s petition with the Food and Drug Administration. Copaxone generated $3.8 billion in sales last year for Teva (NYSE: TEVA), an Israeli generic and branded pharmaceutical company that has its North American headquarters in North Wales, Pa.Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) ended the last trading day at $53.26. Company weekly volatility is calculated as 1.77% and price to cash ratio as 55.89. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) showed a positive weekly performance of 1.60%.

Biogen Idec (NASDAQ:BIIB) has received a consensus recommendation of “Buy” from the twenty-five analysts that are presently covering the stock. Five equities research analysts have rated the stock with a hold recommendation and eighteen have issued a buy recommendation on the company. Biogen Idec Inc (NASDAQ:BIIB) net profit margin is 25.00% and weekly performance is 0.72%. On last trading day company shares ended up $317.59. Analysts mean target price for the company is $347.35. Biogen Idec Inc (NASDAQ:BIIB) distance from 50-day simple moving average is 4.00%.